quinacrine has been researched along with icatibant in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bascands, JL; Bompart, G; Girolami, JP; Pecher, C; Rakotoarivony, J; Tack, JL | 1 |
Duret, JF; El Habach, T; Haury, L; Tiritilli, A | 1 |
2 other study(ies) available for quinacrine and icatibant
Article | Year |
---|---|
Bradykinin-induced in vitro contraction of rat mesangial cells via a B2 receptor type.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic beta-2 Receptor Antagonists; Angiotensin II; Animals; Arginine Vasopressin; Bombesin; Bradykinin; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Membrane; Cells, Cultured; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Endothelins; Fatty Acids, Unsaturated; Glomerular Mesangium; Indomethacin; Kinetics; Naphthalenes; Neomycin; Polycyclic Compounds; Prostaglandin Endoperoxides, Synthetic; Protein Kinase C; Quinacrine; Rats; Receptors, Adrenergic, beta-2; Surface Properties; Tetradecanoylphorbol Acetate; Thromboxane A2; Vasoconstrictor Agents | 1994 |
BK2 but not BK1 receptors mediating contractile response in human umbilical arteries: role of thromboxane A2.
Topics: Bradykinin; Bradykinin B1 Receptor Antagonists; Bradykinin B2 Receptor Antagonists; Dose-Response Relationship, Drug; Endothelium; Humans; Imidazoles; Indomethacin; Masoprocol; Muscle Contraction; Muscle, Smooth, Vascular; Quinacrine; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Thromboxane A2; Umbilical Arteries | 2004 |